Management of Psychosis in Lewy Body Dementia

Non-Pharmacological Interventions

The American Academy of Family Physicians recommends always implementing non-pharmacological interventions before considering medications, including assessing for potentially reversible factors contributing to agitation and implementing structured activities and caregiver support 1

The American Family Physician suggests starting quetiapine at very low doses (12.5mg twice daily) and titrating slowly while monitoring for adverse effects, with a maximum dose of 200mg twice daily 2, 3
The American Family Physician also recommends monitoring for sedation and orthostatic hypotension when using quetiapine 2, 3
The American Journal of Psychiatry notes that the benefits of antipsychotics in dementia are modest at best, with significant risks 4

The American Family Physician recommends avoiding typical antipsychotics (haloperidol, etc.) due to severe sensitivity reactions and high risk of extrapyramidal symptoms 2, 3

The American Academy of Family Physicians recommends closely monitoring for worsening cognition, extrapyramidal symptoms, and orthostatic hypotension, and regularly reassessing the need for continued antipsychotic treatment 1, 2, 3
The American Journal of Psychiatry suggests considering discontinuation of antipsychotic treatment if symptoms improve or if adverse effects develop 4

Always implement non-pharmacological interventions before considering medications, including assessing for potentially reversible factors contributing to agitation 5
Assess the type, frequency, severity, pattern, and timing of symptoms to guide treatment selection 5
Evaluate for pain and other potentially modifiable contributors to symptoms 5
Implement structured activities, reassurance, socialization, and caregiver education/support 6

Antipsychotics should only be used when symptoms are severe, dangerous, or cause significant distress to the patient 5

Before starting any antipsychotic, discuss potential risks and benefits with the patient (if feasible) and surrogate decision-makers 5
Start at low doses and titrate to the minimum effective dose 5
If no clinically significant response after 4 weeks of adequate dosing, taper and withdraw the medication 5

Use quantitative measures to assess treatment response 5
Regularly reassess the need for continued antipsychotic treatment 5
If the patient experiences significant side effects, review risks/benefits to determine if tapering is indicated 5
The American Family Physician guidelines specifically mention quetiapine for agitation in dementia patients 6